HR Execs on the Move

Miriam School the

www.miriamfoundation.com

 
Miriam School the is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Planmeca USA

Planmeca USA is a subsidiary of Planmeca, the largest privately held company in the dental equipment market and one of the industry`s leading manufacturers of dental X-rays and core equipment. With a North American office located in Hoffman Estates, Illinois, and international headquarters in Helsinki, Finland, Planmeca is well established in high-tech dental markets and currently serves 120 countries worldwide.

Post Surgical Manufacturing

Post Surgical Manufacturing is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Portal Instruments

Portal Instruments is transforming the delivery of modern medicines and enhancing the standard of care for chronic diseases. Portal`s unique platform technology is capable of injecting today`s new biological drugs, regardless of volume or viscosity, with minimal sensation and time, providing the patient with enabling connectivity to optimize their disease challenges. The computer-controlled delivery technology is silent, innocuous, and highly customizable across a large variety of medical, animal, agricultural, and cosmetic applications.

Knueppel HealthCare Services

Knueppel HealthCare Services is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Endotronix

Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure. The Cordella™ Heart Failure System includes a cloud-based disease-management system and a breakthrough implantable wireless pulmonary artery pressure sensor. The seamlessly integrated system enables proactive management and early detection of worsening heart failure, which promotes ongoing therapeutic interventions to improve quality of life, reduce hospital readmissions, and lower care costs.